| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/10/2010 | EP2150115A1 Cyclopropyl pyrrolidine orexin receptor antagonists |
| 02/10/2010 | EP2150114A1 Oxo bridged diazepan orexin receptor antagonists |
| 02/10/2010 | EP2150112A1 2-substituted indole derivatives as calcium channel blockers |
| 02/10/2010 | EP2150111A1 Substituted 1,3-dioxanes useful as ppar modulators |
| 02/10/2010 | EP2150110A1 Pharmaceutical compositions for the treatment of pain |
| 02/10/2010 | EP2150109A1 Pharmaceutical use of substituted amides |
| 02/10/2010 | EP2086965B1 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
| 02/10/2010 | EP2066678B1 Spiro antibiotic derivatives |
| 02/10/2010 | EP1833805B1 New 3-phenylpropionic acid derivatives for the treatment of diabetes |
| 02/10/2010 | EP1817287B1 Aromatic ether derivatives useful as thrombin inhibitors |
| 02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/10/2010 | EP1701951B1 Modulators of peripheral 5-ht receptors |
| 02/10/2010 | EP1699800B1 Bicyclic heterocyclic p-38 kinase inhibitors |
| 02/10/2010 | EP1697498B1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 02/10/2010 | EP1618102B1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 02/10/2010 | EP1525191B1 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 02/10/2010 | EP1499331B1 Salt solution for colon cleansing |
| 02/10/2010 | EP1490365B1 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 02/10/2010 | EP1411932B1 Substituted oxazolidinones for combinational therapy |
| 02/10/2010 | EP1404659B1 4-aryl quinols and analogs thereof as therapeutic agents |
| 02/10/2010 | EP1383924B1 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof |
| 02/10/2010 | EP1278546B1 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| 02/10/2010 | CN101646443A Prompt nucleic acid delivery carrier composition |
| 02/10/2010 | CN101646442A Therapeutic or prophylactic agent for vasoconstriction |
| 02/10/2010 | CN101646441A Suspension-type eye drop preparation comprising fluorometholone |
| 02/10/2010 | CN101646440A Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents |
| 02/10/2010 | CN101646439A Reduction of overweight or obesity |
| 02/10/2010 | CN101646438A Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine |
| 02/10/2010 | CN101646437A Compounds and compositions as channel activating protease inhibitors |
| 02/10/2010 | CN101646436A Use of antagonists of oxytocin and/or vasopressin |
| 02/10/2010 | CN101646435A 6, 9-disubstituted purine derivatives and their use for treating skin |
| 02/10/2010 | CN101646434A Use of an adenosine antagonist |
| 02/10/2010 | CN101646433A Anti-resorptive and bone building dietary supplements and methods of use |
| 02/10/2010 | CN101646432A Methods for treating disruptive behavior disorders |
| 02/10/2010 | CN101646431A Polyelectrolyte precipitation and purification of proteins |
| 02/10/2010 | CN101646430A New sigma(s)-receptor ligands with anti-apoptotic and/or pro-apoptotic properties over cellular biochemical mechanisms, with neuroprotective, anti-cancer, anti-metastatic and anti-(chronic) inflammato |
| 02/10/2010 | CN101646429A Ataractic agent and functional food |
| 02/10/2010 | CN101646428A Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof |
| 02/10/2010 | CN101646427A Akt活性抑制剂 Akt activity inhibitor |
| 02/10/2010 | CN101646426A Fatty acid alcohols |
| 02/10/2010 | CN101646425A Method to enhance tissue regeneration |
| 02/10/2010 | CN101643789A RNA interference mediating small RNA molecules |
| 02/10/2010 | CN101643732A A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 02/10/2010 | CN101642467A Long-acting disinfection paste |
| 02/10/2010 | CN101642466A Preparation method of composition containing pilose antler polysaccharides and having function of reducing blood lipids |
| 02/10/2010 | CN101642465A Application of Kadsura heteroclite (Roxb.) Craib polysaccharide of Guangdong province for preparing medicaments for preventing and/or treating senile dementia |
| 02/10/2010 | CN101642464A Hubei polysaccharide in ophiopogon japonicus for treating type II diabetes and method for preparing same |
| 02/10/2010 | CN101642463A Tumor inhibitor NRN1SR4 |
| 02/10/2010 | CN101642462A Tumor inhibitor NRN1SR42 |
| 02/10/2010 | CN101642461A Drug composition of iguratimod and glucosamine, preparation method and drug application thereof |
| 02/10/2010 | CN101642460A Compound solution of diclazuril for curing avian coccidium infection and preparation method thereof |
| 02/10/2010 | CN101642459A Combination dosage form containing a cholesterol -lowering agent, an inhibitor of the renin-angiotensin, and aspirin |
| 02/10/2010 | CN101642458A Use of cyclopamine in the treatment of psoriasis and other skin disorders |
| 02/10/2010 | CN101642457A Medicinal composition for treating benign prostatic hyperplasia |
| 02/10/2010 | CN101642456A Medicinal composition for treating benign prostatic hyperplasia |
| 02/10/2010 | CN101642455A Nerve-soothing capsule |
| 02/10/2010 | CN101642454A Application of berberine in medicament for treating hepatitis B virus infection |
| 02/10/2010 | CN101642453A Medicinal preparation comprising Epothilone B |
| 02/10/2010 | CN101642452A Radiation sensitizer used for brain tumor |
| 02/10/2010 | CN101642451A New application of amiodarone and derivatives thereof |
| 02/10/2010 | CN101642450A New application of dicaffeoylquinic acid |
| 02/10/2010 | CN101642449A Skin mucous membrane disinfectants and preparation method thereof |
| 02/10/2010 | CN100588655C Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 02/10/2010 | CN100588649C Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof |
| 02/10/2010 | CN100588647C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/10/2010 | CN100588644C Eugenol ibuprofen ester medical compound and its preparation and preparation method |
| 02/10/2010 | CN100588405C Deoxyuridine powder injection and its preparing method |
| 02/10/2010 | CN100588404C Chinese traditional medicine compound injection and preparation method thereof |
| 02/10/2010 | CN100588403C Dripping pills of centella total saponin and its preparation process |
| 02/10/2010 | CN100588402C Use of natural mulberry glucoside |
| 02/10/2010 | CN100588401C Method for preparing sulfonamide compound liposome and its formulation |
| 02/10/2010 | CN100588400C Fast disintegrant containing paroxetine |
| 02/10/2010 | CN100588399C Freeze-dried temzolomide powder for injection and its preparing process |
| 02/10/2010 | CN100588398C Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances |
| 02/10/2010 | CN100588397C Armillarisin A solution preparation and its preparing method |
| 02/10/2010 | CN100588396C Composition and methods for treatment of hyperplasia |
| 02/10/2010 | CN100588395C Analgesic and anti-inflammatory compositions containing cox-2 inhibitors |
| 02/10/2010 | CN100588394C Compound tablet capable of controlling release of effective component after oral administration, and preparation method thereof |
| 02/10/2010 | CN100588393C Use of symipristone analog for treating depression |
| 02/10/2010 | CN100588392C A pharmaceutical composition capable of improving boar reproductive performance |
| 02/10/2010 | CN100588391C Single long acting slow-release tablet for deterring abuse of medicine |
| 02/09/2010 | USRE41109 Includes sulfuric acid combined with distilled water and ammonium sulfate under at least 15 psi pressure in a pressurized container, heated to approximately 800 degrees F. or more for at least 3 hours, stabilized with 10 percent of original mixture; for preserving food, and for treatment of melanoma |
| 02/09/2010 | US7659429 A chemical intermediate 2-methyl,4-pentafluorosulfanylaniline for theNHE-1 enzyme inhibitors, 2-methyl,4-pentafluorosulanylbenzoylguanidine;cardiovascular disorders; antiporters; industrial scale; cost efficiency |
| 02/09/2010 | US7659412 Benzofuran derivatives useful for treating hyper-proliferative disorders |
| 02/09/2010 | US7659411 Process for producing 2-acylthiophene compound |
| 02/09/2010 | US7659409 Catalytic reduction with ruthenium/diphenylethylenediamine derivative; amidation, deesterification |
| 02/09/2010 | US7659408 Especially in which the amide nitrogen is substituted with an adamantyl group, e.g., N-adamantyl-4-chloro-5-(o-fluorophenyl)-1-methyl-3-pyrazolecarboxamide; treating hyperglycemia, diabetes or insulin resistance |
| 02/09/2010 | US7659407 Pharmaceutical compounds |
| 02/09/2010 | US7659405 Protease inhibitor; viricides; purity; crystal structure; mixing tank |
| 02/09/2010 | US7659404 Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors |
| 02/09/2010 | US7659403 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-[methyl(3-(2-[(thiophen-2-ylmethyl)amino]ethylcarbamoyl)benzoyl)amino]ethyl)piperidin-4-yl ester |
| 02/09/2010 | US7659402 use as pain relievers, gastrointestinal disorders; 2-Amino-3-aryl-1-[3-((hetero)aryl)piperidin-1-yl]-propan-1-one compounds |
| 02/09/2010 | US7659400 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging |
| 02/09/2010 | US7659399 1-thia-2,4a-diaza-cyclopenta[b]napththalene-3,4-diones and related compounds as anti-infective agents |
| 02/09/2010 | US7659394 Substituted morpholine compounds for the treatment of central nervous system disorders |
| 02/09/2010 | US7659391 Method for the in vitro synthesis of short double stranded RNAs |
| 02/09/2010 | US7659387 Transgenic mammals introduced a Period 1 promoter that confers rhythmical expression |
| 02/09/2010 | US7659344 Shaped articles containing poly(vinylpyrrolidone)-iodine complex |
| 02/09/2010 | US7659314 PH-sensitive polymeric micelles for drug delivery |
| 02/09/2010 | US7659313 3-(4-hydroxybenzylidene)-2-(2,5-dihydroxyphenyl)-1-(4-hydroxyphenyl)indane-4,6-diol as lipase, alpha -amylase and alpha -glucosidase inhibitor in a mammal; plant medicine; antiobesity agent |